CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Total	Series A Preferred	Series B1 Preferred Stock	Series B Preferred Stock	Common Stock	Common Stock Series A Preferred	Common Stock Series B1 Preferred Stock	Common Stock Series B Preferred Stock	Preferred stock Series A Preferred	Preferred stock Series C Preferred	Additional Paid-In Capital	Additional Paid-In Capital Series B1 Preferred Stock	Additional Paid-In Capital Series B Preferred Stock	Retained Earnings	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2019					43,395,563				419,859	0
Beginning balance at Dec. 31, 2019	$ 23,102,026				$ 43,396				$ 420	$ 0	$ 81,527,351			$ (59,246,514)	$ 777,373
Increase (Decrease) in Stockholders' Equity
Purchase of shares of consolidated subsidiary	(71,171)										(71,171)
Share based compensation expense	163,269										163,269
Adjustment of carrying amount of non-controlling interest	9,091,068										9,091,068
Conversion of Series B/B-1 Preferred stock to common (in shares)					2,159,278
Conversion of Series B/B-1 Preferred stock to common	3,368,474				$ 2,159						3,366,315
Dividends on Series B and B1	(344,499)													(344,499)
Accretion of discount on Series B and B1	(932,003)													(932,003)
Accretion of redeemable non-controlling interest to redemption value	(10,966,349)													(10,966,349)
Net income (loss)	2,390,251													2,788,860	(398,609)
Less: amount attributable to redeemable non-controlling interest	517,877														517,877
Ending balance (in shares) at Mar. 31, 2020					45,554,841				419,859	0
Ending balance at Mar. 31, 2020	26,318,943				$ 45,555				$ 420	$ 0	94,076,832			(68,700,505)	896,641
Beginning balance (in shares) at Dec. 31, 2019					43,395,563				419,859	0
Beginning balance at Dec. 31, 2019	23,102,026				$ 43,396				$ 420	$ 0	81,527,351			(59,246,514)	777,373
Increase (Decrease) in Stockholders' Equity
Adjustment of carrying amount of non-controlling interest	9,091,068
Accretion of discount on Series B and B1			$ (646,031)	$ (854,364)
Net income (loss)	(8,453,392)
Ending balance (in shares) at Sep. 30, 2020					45,554,841				419,859	0
Ending balance at Sep. 30, 2020	11,179,859				$ 45,555				$ 420	$ 0	94,404,520			(84,323,362)	1,052,726
Beginning balance (in shares) at Mar. 31, 2020					45,554,841				419,859	0
Beginning balance at Mar. 31, 2020	26,318,943				$ 45,555				$ 420	$ 0	94,076,832			(68,700,505)	896,641
Increase (Decrease) in Stockholders' Equity
Share based compensation expense	156,539										156,539
Dividends on Series B and B1	(360,217)													(360,217)
Accretion of discount on Series B and B1	(539,235)													(539,235)
Accretion of redeemable non-controlling interest to redemption value	(1,381,889)													(1,381,889)
Net income (loss)	(8,888,473)													(8,997,638)	109,165
Less: amount attributable to redeemable non-controlling interest	(127,044)														(127,044)
Ending balance (in shares) at Jun. 30, 2020					45,554,841				419,859	0
Ending balance at Jun. 30, 2020	15,178,624				$ 45,555				$ 420	$ 0	94,233,371			(79,979,484)	878,762
Increase (Decrease) in Stockholders' Equity
Share based compensation expense	171,149										171,149
Accretion of redeemable non-controlling interest to redemption value	(1,287,559)													(1,287,559)
Dividends on Series B and B1	(591,777)													(591,777)
Accretion of discount on Series B and B1	(29,157)													(29,157)
Net income (loss)	(1,955,170)													(2,435,385)	480,215
Less: amount attributable to redeemable non-controlling interest	(306,251)														(306,251)
Ending balance (in shares) at Sep. 30, 2020					45,554,841				419,859	0
Ending balance at Sep. 30, 2020	11,179,859				$ 45,555				$ 420	$ 0	94,404,520			(84,323,362)	1,052,726
Beginning balance (in shares) at Dec. 31, 2020					45,554,841				419,859	0
Beginning balance at Dec. 31, 2020	5,924,749				$ 45,555				$ 420	$ 0	94,569,674			(90,008,778)	1,317,878
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					22,992		1,079,753
Exercise of options/ B1 warrants	0		2,757,957		$ 23		$ 1,080				(23)	$ 2,756,877
Exchanges of Series B Preferred stock to common (in shares)					2,359,494
Exchanges of Series B Preferred stock to common	4,747,250				$ 2,359						4,114,570			630,321
Share based compensation expense	150,514										150,514
Conversion of Series B/B-1 Preferred stock to common (in shares)							2,087,195	638,224
Conversion of Series B/B-1 Preferred stock to common			3,256,024	1,978,494			$ 2,087	$ 638				3,253,937	$ 1,977,856
Dividends on Series B and B1	(372,183)													(372,183)
Accretion of discount on Series B and B1	(223,727)													(223,727)
Accretion of redeemable non-controlling interest to redemption value	(373,748)													(373,748)
Net income (loss)	2,965,338													974,369	1,990,969
Less: amount attributable to redeemable non-controlling interest	(1,542,402)														(1,542,402)
Ending balance (in shares) at Mar. 31, 2021					51,742,499				419,859	0
Ending balance at Mar. 31, 2021	19,268,266				$ 51,742				$ 420	$ 0	106,823,405			(89,373,746)	1,766,445
Beginning balance (in shares) at Dec. 31, 2020					45,554,841				419,859	0
Beginning balance at Dec. 31, 2020	5,924,749				$ 45,555				$ 420	$ 0	94,569,674			(90,008,778)	1,317,878
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					1,795,840
Accretion of discount on Series B and B1			(507,282)	0
Net income (loss)	(2,346,808)
Ending balance (in shares) at Sep. 30, 2021					63,003,766				385,601	0
Ending balance at Sep. 30, 2021	37,341,970				$ 63,004				$ 386	$ 0	136,905,764			(101,475,299)	1,848,115
Beginning balance (in shares) at Mar. 31, 2021					51,742,499				419,859	0
Beginning balance at Mar. 31, 2021	19,268,266				$ 51,742				$ 420	$ 0	106,823,405			(89,373,746)	1,766,445
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					505,376		156,792
Exercise of options/ B1 warrants	229,512		1,634,566		$ 505		$ 157				229,007	1,634,409
Stock Unissued During Period Value Exercise Of B1 Warrants			1,185,831									1,185,831
Exercise of options to common- unissued	474,866										474,866
Leverage Lubricants contribution	(13,491)														(13,491)
Share based compensation expense	205,039										205,039
Conversion of Series A Preferred stock to common (in shares)						28,257			(28,257)
Conversion of Series A Preferred stock to common		$ 0				$ 28			$ (28)
Conversion of Series B/B-1 Preferred stock to common (in shares)							5,634,889	1,841,406
Conversion of Series B/B-1 Preferred stock to common			8,790,417	5,708,359			$ 5,635	$ 1,842				8,784,782	5,706,517
Conversion of Series B Preferred stock to common-unissued				759,983									759,983
Accretion of discount on Series B and B1	(283,555)													(283,555)
Accretion of redeemable non-controlling interest to redemption value	(388,245)													(388,245)
Net income (loss)	(15,956,662)													(19,374,569)	3,417,907
Less: amount attributable to redeemable non-controlling interest	(3,111,743)														(3,111,743)
Ending balance (in shares) at Jun. 30, 2021					59,909,219				391,602	0
Ending balance at Jun. 30, 2021	18,503,143				$ 59,909				$ 392	$ 0	125,803,839			(109,420,115)	2,059,118
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					1,267,472		1,575,918
Exercise of options/ B1 warrants	1,482,387		$ 9,362,629		$ 1,268		$ 1,576				1,481,119	$ 9,361,053
Exercise of options to common- unissued	2,925										2,925
Leverage Lubricants contribution	2,260														2,260
Distribution from VRM LA	(169,368)														(169,368)
Share based compensation expense	257,073										257,073
Conversion of Series A Preferred stock to common (in shares)						6,001			(6,001)
Conversion of Series A Preferred stock to common		$ 0				$ 6			$ (6)
Conversion of Series B/B-1 Preferred stock to common (in shares)								245,156
Conversion of Series B/B-1 Preferred stock to common				$ 0				$ 245					$ (245)
Accretion of redeemable non-controlling interest to redemption value	(414,690)													(414,690)
Net income (loss)	10,644,516													8,359,506	2,285,010
Less: amount attributable to redeemable non-controlling interest	(2,328,905)														(2,328,905)
Ending balance (in shares) at Sep. 30, 2021					63,003,766				385,601	0
Ending balance at Sep. 30, 2021	$ 37,341,970				$ 63,004				$ 386	$ 0	$ 136,905,764			$ (101,475,299)	$ 1,848,115